nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Deep Learning System to Screen Novel Coronavirus Disease 2019 Pneumonia
|
Xu, Xiaowei |
|
|
6 |
10 |
p. 1122-1129 |
artikel |
2 |
A High-Throughput, Multi-Index Isothermal Amplification Platform for Rapid Detection of 19 Types of Common Respiratory Viruses Including SARS-CoV-2
|
Xing, Wanli |
|
|
6 |
10 |
p. 1130-1140 |
artikel |
3 |
Buying Time for an Effective Epidemic Response: The Impact of a Public Holiday for Outbreak Control on COVID-19 Epidemic Spread
|
Chen, Simiao |
|
|
6 |
10 |
p. 1108-1114 |
artikel |
4 |
Can Masks Be Reused After Hot Water Decontamination During the COVID-19 Pandemic?
|
Wang, Dan |
|
|
6 |
10 |
p. 1115-1121 |
artikel |
5 |
Challenges in the Development of a Vaccine Against COVID-19
|
Chen, Wei |
|
|
6 |
10 |
p. 1067-1069 |
artikel |
6 |
Clinical Characteristics and Outcomes of Type 2 Diabetes Patients Infected with COVID-19: A Retrospective Study
|
Chen, Yingyu |
|
|
6 |
10 |
p. 1170-1177 |
artikel |
7 |
Clinical Significance of the Correlation between Changes in the Major Intestinal Bacteria Species and COVID-19 Severity
|
Tang, Lingling |
|
|
6 |
10 |
p. 1178-1184 |
artikel |
8 |
Clinical Study of Mesenchymal Stem Cell Treatment for Acute Respiratory Distress Syndrome Induced by Epidemic Influenza A (H7N9) Infection: A Hint for COVID-19 Treatment
|
Chen, Jiajia |
|
|
6 |
10 |
p. 1153-1161 |
artikel |
9 |
Core Outcome Set for Clinical Trials on Coronavirus Disease 2019 (COS-COVID)
|
Jin, Xinyao |
|
|
6 |
10 |
p. 1147-1152 |
artikel |
10 |
COVID-19 Fight Enlists Digital Technology: Contact Tracing Apps
|
Leslie, Mitch |
|
|
6 |
10 |
p. 1064-1066 |
artikel |
11 |
COVID-19 Fight Enlists Digital Technology: Tracking an Elusive Foe
|
Leslie, Mitch |
|
|
6 |
10 |
p. 1061-1063 |
artikel |
12 |
Editorial for the Special Issue on COVID-19
|
Li, Xiaohong |
|
|
6 |
10 |
p. 1057-1060 |
artikel |
13 |
Efficacy and Safety of Triazavirin Therapy for Coronavirus Disease 2019: A Pilot Randomized Controlled Trial
|
Wu, Xiaoke |
|
|
6 |
10 |
p. 1185-1191 |
artikel |
14 |
Ethical Reflection on the Emergency Engineering Management of COVID-19 Epidemic Prevention and Control
|
Fang, Dongping |
|
|
6 |
10 |
p. 1070-1072 |
artikel |
15 |
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
|
Cai, Qingxian |
|
|
6 |
10 |
p. 1192-1198 |
artikel |
16 |
Implementation of Clinical Diagnostic Criteria and Universal Symptom Survey Contributed to Lower Magnitude and Faster Resolution of the COVID-19 Epidemic in Wuhan
|
Wei, Yongyue |
|
|
6 |
10 |
p. 1141-1146 |
artikel |
17 |
Mesenchymal Stem Cells Represent a Potential Therapeutic Option for Coronavirus Disease 2019-Related Acute Respiratory Distress Syndrome
|
Zhao, Xuan |
|
|
6 |
10 |
p. 1073-1075 |
artikel |
18 |
Natural Host–Environmental Media–Human: A New Potential Pathway of COVID-19 Outbreak
|
Li, Miao |
|
|
6 |
10 |
p. 1085-1098 |
artikel |
19 |
SARS-CoV-2 Entry Factors: ACE2 and TMPRSS2 Are Expressed in Peri-Implantation Embryos and the Maternal–Fetal Interface
|
Chen, Wei |
|
|
6 |
10 |
p. 1162-1169 |
artikel |
20 |
Strategies and Advances in Combating COVID-19 in China
|
Liu, Wei |
|
|
6 |
10 |
p. 1076-1084 |
artikel |
21 |
The Efficacy and Safety of Triazavirin for COVID-19: A Trial Protocol
|
Wu, Xiaoke |
|
|
6 |
10 |
p. 1199-1204 |
artikel |
22 |
The Scientific Foundation of Chinese Herbal Medicine against COVID-19
|
Leung, Elaine Lai-Han |
|
|
6 |
10 |
p. 1099-1107 |
artikel |